BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23/11/1999

Guidance for Industry on Changes to an Approved NDA or ANDA; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Changes to an Approved NDA or ANDA.'' This guidance is intended to assist applicants in determining how they should report changes to an approved new drug application (NDA) or abbreviated new drug application (ANDA).

Source: Federal Register — Food and Drug AdministrationOpen original release →